Today in News History
On July 12, several notable moments in the history of News stand out. In 1895, Buckminster Fuller, American architect and engineer, designed the Montreal Biosphère (died 1983) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1948, Ben Burtt, American director, screenwriter, and sound designer was born. In 1949, Rick Hendrick, American businessman, founded Hendrick Motorsports was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1990, Rachel Brosnahan, American actress was born. In 1995, Jordyn Wieber, American gymnast was born. In 1998, Serge Lemoyne, Canadian painter (born 1941) passed away. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2024, Ruth Westheimer, German-American sex therapist (born 1928) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow
Narrative Intelligence Brief
This article was published by Seeking Alpha, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Seeking Alpha, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Seeking Alpha
July 12, 2026
Mar Vista U.S. Quality Premier Portfolio Q2 2026 Portfolio Activity
July 12, 2026
Mar Vista U.S. Quality Premier Portfolio Q2 2026 Commentary
July 12, 2026
Kevin Warsh's First FOMC Meeting Was A Success - But Where Does It Lead?
July 12, 2026
ZWB:CA: Strong Q2 But Rated As Hold Due To Valuation Concerns
July 12, 2026
Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinal"
Argentina beat Switzerland to set up World Cup semifinal against England
[Photo] JUST IN: 🇦🇷 Argentina officially advances to the FIFA World Cup semifinal after defeat [...]
Argentina set up titanic World Cup semifinal against England with extra-time victory over Switzerland after Breel Embolo's embarrassing red card
How other outlets are covering this story
Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
5 sources
Left 40%
Center 40%
Right 20%
Seeking Alpha
· Jun 25, 2026
Resverlogix Corp. (RVX:CA) Shareholder/Analyst Call - Slideshow
Resverlogix Corp. (RVX:CA) Shareholder/Analyst Call - Slideshow
The Motley Fool
· Jul 10, 2026
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
Additional blockbuster drugs may be on the horizon.
Investing.com
· Jul 7, 2026
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress
The Eastern Herald
· Jul 8, 2026
Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet
Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing
Bloomberg
· Jul 1, 2026
Dealmakers 'Unlock the Magic' with Care Bears Sale
Jeff Collins, Managing Partner at Cloverlay, joins Dani Burger on Bloomberg Deals. IVEST Consumer Partners and Cloverlay announced the sale of Care Bears to Authentic Brands Group. They discuss the deal and the value of intellectual property. (Source: Bloomberg)
Topics:
Related coverage for "Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow": Seeking Alpha — Resverlogix Corp. (RVX:CA) Shareholder/Analyst Call - Slideshow. The Motley Fool — Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?. Investing.com — H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress. The Eastern Herald — Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet. Bloomberg — Dealmakers 'Unlock the Magic' with Care Bears Sale